FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
0.8831
-0.0303 (-3.32%)
May 21, 2025, 3:39 PM - Market open

FibroBiologics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
8.6713.999.162.270.41-
Cash & Short-Term Investments
8.6713.999.162.270.41-
Cash Growth
6.24%52.63%304.37%456.76%--
Receivables
---0.3--
Prepaid Expenses
0.640.230.040.030.04-
Other Current Assets
0.020.020.020.030.02-
Total Current Assets
9.3314.239.222.630.47-
Property, Plant & Equipment
2.12.222.612.2--
Total Assets
11.4316.4511.824.820.47-
Accounts Payable
1.422.71.440.760.23-
Short-Term Debt
5.849.17-5.451.53-
Current Portion of Leases
0.410.40.360.33--
Other Current Liabilities
0.540.467.380.54--
Total Current Liabilities
8.2112.739.187.071.76-
Long-Term Leases
0.870.981.391.75--
Total Liabilities
9.0813.7110.578.821.76-
Common Stock
--00-1.17
Additional Paid-In Capital
42.8338.2525.612.41--
Retained Earnings
-40.48-35.52-24.36-7.87-2.75-1.17
Comprehensive Income & Other
---1.461.46-
Shareholders' Equity
2.352.741.25-4-1.29-
Total Liabilities & Equity
11.4316.4511.824.820.47-
Total Debt
7.1210.551.757.521.53-
Net Cash (Debt)
1.553.437.42-5.26-1.12-
Net Cash Growth
-74.36%-53.72%----
Net Cash Per Share
0.050.100.26-0.19-0.13-
Filing Date Shares Outstanding
38.2637.7432.4928.2340.738.75
Total Common Shares Outstanding
37.7435.0928.2328.2340.738.75
Working Capital
1.121.50.03-4.45-1.29-
Book Value Per Share
0.060.080.04-0.14-0.03-
Tangible Book Value
2.352.741.25-4-1.29-
Tangible Book Value Per Share
0.060.080.04-0.14-0.03-
Machinery
1.071.030.84---
Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q